Pharma-Bio Serv (PBSV) Net Cash Flow Growth (3y) (2013 - 2026)

Pharma-Bio Serv (PBSV) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 31.95%
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -1,545.42%
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -23.22%
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 50.05%
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -28.47%
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Pharma-Bio Serv 12.37 Mn 3.89 Mn 902,041.00 -89.19%

Historic Data

Download Data
DateValue
Apr 30, 2026 -89.19%
Jan 31, 2026 32.46%
Oct 31, 2025 -63.70%
Jul 31, 2025 19.34%
Apr 30, 2025 -33.97%
Jan 31, 2025 31.34%
Oct 31, 2024 -37.06%
Jul 31, 2024 90.78%
Apr 30, 2024 0.43%
Jan 31, 2024 -61.43%
Oct 31, 2023 182.61%
Jul 31, 2023 -84.48%
Apr 30, 2023 32.63%
Jan 31, 2023 -218.88%
Oct 31, 2022 -29.42%
Jul 31, 2022 54.81%
Apr 30, 2022 -86.02%
Jan 31, 2022 -104.70%
Oct 31, 2021 39.73%
Jul 31, 2021 -36.31%